busulfan has been researched along with Epidermolysis Bullosa Dystrophica in 1 studies
Epidermolysis Bullosa Dystrophica: Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recessive dystrophic epidermolysis bullosa is a severe, incurable, inherited blistering disease caused by COL7A1 mutations." | 1.42 | Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa. ( Baxter-Lowe, L; Bruckner, A; Cairo, MS; Chen, M; Christiano, AM; Fabricatore, S; Geyer, MB; Giller, R; Harel, S; Kandel, J; Kiuru, M; LeBoeuf, N; McGrath, J; Morel, KD; Radhakrishnan, K; Uitto, J; Umegaki, N; Woodley, D, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geyer, MB | 1 |
| Radhakrishnan, K | 1 |
| Giller, R | 1 |
| Umegaki, N | 1 |
| Harel, S | 1 |
| Kiuru, M | 1 |
| Morel, KD | 1 |
| LeBoeuf, N | 1 |
| Kandel, J | 1 |
| Bruckner, A | 1 |
| Fabricatore, S | 1 |
| Chen, M | 1 |
| Woodley, D | 1 |
| McGrath, J | 1 |
| Baxter-Lowe, L | 1 |
| Uitto, J | 1 |
| Christiano, AM | 1 |
| Cairo, MS | 1 |
1 other study available for busulfan and Epidermolysis Bullosa Dystrophica
| Article | Year |
|---|---|
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Busulfan; Child; Collagen Type VII; Epidermolysis Bu | 2015 |